IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Epirus Biopharmaceuticals in

CUSIP: 29428P107 | 79 institutional holders

Quarters

Q3 2019Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2019

Private Capital Group, LLC400
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Private Capital Group, LLC
400$00.0%N/AN/AWest Hartford, CT2019-11-13